Principal Financial Group Inc. Sells 883,593 Shares of Healthpeak Properties, Inc. $DOC

Principal Financial Group Inc. reduced its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 3.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,984,868 shares of the real estate investment trust’s stock after selling 883,593 shares during the quarter. Principal Financial Group Inc.’s holdings in Healthpeak Properties were worth $516,760,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Mather Group LLC. acquired a new stake in shares of Healthpeak Properties during the 3rd quarter worth about $25,000. City Holding Co. acquired a new position in Healthpeak Properties in the third quarter valued at about $26,000. Rexford Capital Inc. bought a new stake in Healthpeak Properties during the second quarter worth about $28,000. Sound Income Strategies LLC acquired a new stake in shares of Healthpeak Properties during the third quarter worth approximately $28,000. Finally, Elevation Point Wealth Partners LLC bought a new position in shares of Healthpeak Properties in the second quarter valued at approximately $32,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Trading Up 0.5%

DOC opened at $17.22 on Friday. The firm has a 50 day simple moving average of $17.00 and a 200 day simple moving average of $17.65. Healthpeak Properties, Inc. has a fifty-two week low of $15.71 and a fifty-two week high of $21.28. The company has a market cap of $11.97 billion, a price-to-earnings ratio of -344.33, a price-to-earnings-growth ratio of 4.32 and a beta of 1.12. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.22 and a quick ratio of 1.22.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a $0.1017 dividend. This represents a c) annualized dividend and a dividend yield of 7.1%. The ex-dividend date is Tuesday, March 17th. Healthpeak Properties’s dividend payout ratio (DPR) is currently -2,440.00%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Wells Fargo & Company increased their price target on Healthpeak Properties from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 25th. Jefferies Financial Group cut Healthpeak Properties from a “buy” rating to a “hold” rating and decreased their target price for the stock from $21.00 to $17.00 in a report on Monday, December 15th. The Goldman Sachs Group assumed coverage on Healthpeak Properties in a report on Friday, January 9th. They issued a “neutral” rating and a $17.00 price target for the company. Evercore ISI decreased their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an “outperform” rating on the stock in a report on Monday, December 15th. Finally, Weiss Ratings upgraded shares of Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 26th. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $19.67.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.